This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Nancy, Universite Dé Lorraine. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 93 
Years Active: 2024
Title: Danièle Bensoussan: Innovator in Stem Cell Research
Introduction
Danièle Bensoussan is a notable inventor based in Nancy, France. He has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of mesenchymal stem cells.
Latest Patents
Bensoussan holds a patent for "Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis." This patent discloses a method for preparing human mesenchymal stem cells derived from Wharton's jelly, along with their therapeutic uses, especially for treating sepsis and septic shock. The treatment involves administering a pharmaceutical composition that includes these stem cells and a pharmaceutically acceptable excipient.
Career Highlights
Throughout his career, Danièle Bensoussan has worked with esteemed institutions such as Université de Lorraine and Centre Hospitalier Régional Universitaire de Nancy. His work has focused on advancing the understanding and application of stem cell therapies.
Collaborations
Bensoussan has collaborated with notable colleagues, including Sébastien Gibot and Loïc Reppel, contributing to the advancement of research in his field.
Conclusion
Danièle Bensoussan's innovative work in stem cell research highlights the potential of mesenchymal stem cells in treating critical conditions like sepsis. His contributions continue to influence the medical research landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile